RecruitingNot ApplicableNCT06363565

Effects of Supplementation of Compound Nutrients on Plasma Homocysteine in Chinese Adults

Study on the Effect of Compound Nutrients on Reducing Homocysteine -- A 3-month Double-blind Randomized Controlled Trial


Sponsor

Sun Yat-sen University

Enrollment

220 participants

Start Date

Jun 1, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to determine whether supplementation of compound nutrients, including folic acid, vitamin B6, vitamin B12, and betaine, will decrease the level of plasma homocysteine in Chinese adults with homocysteine levels above 10 μmol/L.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria4

  • Aged 18 - 65 years;
  • Concentration of plasma homocysteine is between 10 and 100 μmol/L;
  • Free from any supplements or drugs that may decrease plasma homocysteine concentration for at least 1 month prior to the beginning of study;
  • Willing to participate in the study and sign informed consent.

Exclusion Criteria5

  • Pregnant or lactating women;
  • Allergic physique or allergic to our compound nutrients tablets;
  • Complicated with severe diseases;
  • Unable to conduct study procedures;
  • Participating in any other intervention studies.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTsupplementation of compound nutrients

Folic acid, vitamin B6, vitamin B12, and betaine per day orally for 12 weeks.

DIETARY_SUPPLEMENTplacebo control

The placebo is an excipient and the color, flavor, shape, taste, and weight are same with the tablet of supplement.


Locations(1)

SunYat-sen University

Guangzhou, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06363565


Related Trials